Expanding the spectrum of TBL1XR1 deletion: Report of a patient with brain and cardiac malformations.

Eur J Med Genet

Programa de Pós-graduação em Ciências da Saúde, Universidade de Brasília, Brasília, Brazil; Departamento de Genética e Morfologia, Instituto de Ciências Biológicas, Universidade de Brasília, Brasília, Brazil; Programa de Pós-graduação em Biologia Animal, Universidade de Brasília, Brasília, Brazil. Electronic address:

Published: January 2018

The TBL1XR1 gene product is a nuclear protein ubiquitously produced. The protein is a component of SMRT/N-CoR co-repressor complexes and participates in the molecular switch of specific gene transcription. Deletions of the TBL1XR1 gene have been described in two families to date, both presenting intellectual disability and dysmorphisms. Rare recurrent chromosomal micro-rearrangements, particularly those involving single genes, represent a challenge for clinicians to ensure correlation with phenotype due to the paucity of previously described cases. Here we present a patient harbouring a TBL1XR1 gene deletion detected by chromosome microarray analysis. In addition to intellectual disability, the patient presents dysmorphic features and multiple cardiac malformations, together with brain malformation, thus contributing to the phenotypic characterization of this rare microdeletion and to the TBL1XR1 gene function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2017.10.008DOI Listing

Publication Analysis

Top Keywords

tbl1xr1 gene
16
cardiac malformations
8
intellectual disability
8
tbl1xr1
5
gene
5
expanding spectrum
4
spectrum tbl1xr1
4
tbl1xr1 deletion
4
deletion report
4
report patient
4

Similar Publications

Mechanistic insights into retinoic-acid treatment for autism in the improvement of social behavior: Evidence from a multi omics study in rats.

Neuropharmacology

March 2025

Department of Child Health Care, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, 510623, China. Electronic address:

Background: Autism spectrum disorder (ASD) is a lifelong condition. It is characterized by complex etiologies, including disruptions in exogenous retinoic acid (RA) signaling, which may serve as an environmental risk factor. Targeting the RA pathway presents a promising therapeutic avenue, though the precise mechanisms remain to be elucidated.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and prognostic factors of induction therapy for secondary central nervous system lymphoma (SCNSL) using patient data from a hospital between 2010 and 2021.
  • It involves 37 patients with diffuse large B-cell lymphoma and finds a 2-year overall survival rate of 46.01% with varying outcomes based on treatment type.
  • The analysis indicates that age, sex, and disease stage are significant prognostic factors, suggesting that a combination of HD-MTX and TMZ could enhance patient outcomes while emphasizing the usefulness of gene sequencing for prognosis evaluation.
View Article and Find Full Text PDF

1. In the following experiment meat quality traits of a Gushi-Anka F2 resource population were measured, and their heritability estimated. Intramuscular fat (IMF) had medium heritability (0.

View Article and Find Full Text PDF

Macrophages are required for our body's development and tissue repair and protect against microbial attacks. We previously reported a crucial role for regulation of mRNA 3'-end cleavage and polyadenylation (C/P) in monocyte to macrophage differentiation. The CFIm25 subunit of the C/P complex showed a striking increase upon differentiation of monocytes with Phorbol Myristate Acetate, suggesting that it promotes this process.

View Article and Find Full Text PDF

Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma.

J Blood Med

September 2024

Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, 100191, People's Republic of China.

Background: The application of rituximab has significantly enhanced the overall survival rates in patients with diffuse large B-cell lymphoma (DLBCL). Regrettably, a significant number of patients still progress to relapse/refractory DLBCL (rrDLBCL).

Methods: Herein, we employed targeted sequencing of 55 genes to investigate if gene mutations could predict the progression to rrDLBCL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!